Trial intelligence / Profile preview

Balanced versus unbalanced infusion solutions during elective hip replacement surgery

2009-016043-19Phase 4Completed

Sponsor
Charité – Universitätsmedizin Berlin
Start
Feb 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of ringer solution and electrolytes (2 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Change in standardized base excess after administration of 2 litres of study medication. Started Feb 2010; status: completed.

02

Drugs

ringer solutionelectrolytes

Beyond the preview

Go deeper on 2009-016043-19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-016043-19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call